Date: Dec. 10
Time: 2–3:30 p.m. EST / 8–9:30 p.m. CET
Pulmonary hypertension due to interstitial lung disease is a growing global challenge to diagnose and treat. Join the Pulmonary Hypertension Association, the Pulmonary Fibrosis Foundation and Fundación Contra la Hipertensión Pulmonar to learn about the current state of PH-ILD and the direction of future science, care and global partnership development.
Cardiologist Alejandro Cruz Utrilla will join Roberto Bernardo and Navneet Singh to discuss:
• Current research, diagnosis and management in PH-ILD.
• Emerging science and data-driven trends.
• Global perspectives on PH-ILD.
This webinar will include simultaneous live interpretation in English and Spanish to support inclusive participation across regions.
Speakers
Roberto Bernardo, MD, MS, ATSF
Clinical assistant professor
Adult Pulmonary Hypertension Service
Vera Moulton Wall Center for Pulmonary Vascular Disease
Division of Pulmonary, Allergy & Critical Care Medicine
Stanford University School of Medicine
Navneet Singh, MD, ScM, MBA
Assistant professor of medicine
Associate Fellowship Program Director for Research
Division of Pulmonary, Critical Care & Sleep Medicine
The Warren Alpert Medical School at Brown University
Alejandro Cruz Utrilla, MD
Cardiologist
Pulmonary Hypertension Unit, Department of Cardiology,
Hospital Universitario 12 de Octubre, Madrid, Spain
European Reference Network for Rare Respiratory Diseases
